• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CorVel Announces Revenues and Earnings

    1/30/24 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance
    Get the next $CRVL alert in real time by email

    FORT WORTH, Texas, Jan. 30, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended December 31, 2023. Revenues for the quarter were $202 million, an increase from $179 million in the December quarter of 2022. Earnings per share for the quarter were $0.99, compared to $0.96 in the same quarter of the prior year.  

    Revenues for the nine months ended December 31, 2023 were $588 million, compared to $533 million for the nine months ended December 31, 2022. Earnings per share for the nine months ended December 31, 2023, were $3.27, compared to $2.73 for the same nine-month period in 2022.

    The 2023 calendar year ended with a 34% increase in new business sold with balanced bookings in the Network Solutions and Patient Management business. Customer retention, as measured by Gross Revenue Retention for the year, was 95%, while Net Revenue Retention was 108%. CorVel's practical application of advanced technology and the corresponding program impact drive improved retention in a market with increased churn.

    The Company's payment integrity services have garnered significant attention from large payors and platform vendors seeking proven solutions to address the meaningful growth in medical care ratios. In addition to enhancing current offerings, CERIS has expanded the teams responsible for launching additional reviews in the market.

    The implementation of generative AI initiatives has been proven to boost the efficiency and effectiveness of both the P&C and Commercial Claims teams. These updates have gradually reduced time spent on routine tasks, thus creating more time for essential activities that require critical thinking, directly impacting the user experience and results achieved.

    About CorVel

    CorVel Corporation applies technology including artificial intelligence, machine learning and natural language processing to enhance the managing of episodes of care and the related health care costs. We partner with employers, third-party administrators, insurance companies and government agencies in managing workers' compensation and health, auto and liability services. Our diverse suite of solutions combines our integrated technologies with a human touch. CorVel's customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients.

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

    All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company's current expectations, estimates and projections about the Company, management's beliefs, and certain assumptions made by the Company, and events beyond the Company's control, all of which are subject to change. Such forward-looking statements include, but are not limited to, statements relating to our commercial health-focused operation, improved productivity resulting from automation and augmentation across enterprise business systems. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company's actual results to differ materially and adversely from those expressed in any forward-looking statement, including the risk that the impact of the COVID-19 pandemic on our business, results of operations and financial condition is greater than our initial assessment.

    The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company's filings with the Securities and Exchange Commission, including but not limited to "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2023 and the Company's Quarterly Report on Form 10-Q for the quarters ended June 30, 2023 and September 30, 2023. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.

    CorVel Corporation

    Quarterly Results – Income Statement

    Quarters and Nine months Ended December 31, 2023 (unaudited) and December 31, 2022 (unaudited)

    Quarter EndedDecember 31, 2023  December 31, 2022 
    Revenues$202,303,000  $179,386,000 
    Cost of revenues 160,143,000   139,041,000 
    Gross profit 42,160,000   40,345,000 
    General and administrative 19,798,000   18,128,000 
    Income from operations 22,362,000   22,217,000 
    Income tax provision 5,267,000   5,368,000 
    Net income$17,095,000  $16,849,000 
    Earnings Per Share:     
    Basic$1.00  $0.98 
    Diluted$0.99  $0.96 
    Weighted Shares     
    Basic 17,106,000   17,245,000 
    Diluted 17,326,000   17,487,000 



    Nine Months EndedDecember 31, 2023  December 31, 2022 
    Revenues$588,078,000  $533,119,000 
    Cost of revenues 459,788,000   416,811,000 
    Gross profit 128,290,000   116,308,000 
    General and administrative 55,786,000   54,347,000 
    Income from operations 72,504,000   61,961,000 
    Income tax provision 15,706,000   13,765,000 
    Net income$56,798,000  $48,196,000 
    Earnings Per Share:     
    Basic$3.32  $2.77 
    Diluted$3.27  $2.73 
    Weighted Shares     
    Basic 17,124,000   17,379,000 
    Diluted 17,352,000   17,647,000 
            

    CorVel Corporation

    Quarterly Results – Condensed Balance Sheet

    December 31, 2023 (unaudited) and March 31, 2023

     December 31, 2023  March 31, 2023 
    Cash$106,994,000  $71,329,000 
    Customer deposits 80,838,000   80,022,000 
    Accounts receivable, net 92,657,000   81,034,000 
    Prepaid taxes and expenses 13,903,000   11,385,000 
    Property, net 85,216,000   82,770,000 
    Goodwill and other assets 40,304,000   39,662,000 
    Right-of-use asset, net 25,083,000   27,721,000 
    Total$444,995,000  $393,923,000 
    Accounts and taxes payable$15,133,000  $15,309,000 
    Accrued liabilities 173,254,000   152,578,000 
    Long-term lease liabilities 23,078,000   23,860,000 
    Paid-in capital 229,788,000   218,703,000 
    Treasury stock (784,724,000)  (748,195,000)
    Retained earnings 788,466,000   731,668,000 
    Total$444,995,000  $393,923,000 
            



    Contact: Melissa Storan
    Phone: 949-851-1473
    www.corvel.com


    Primary Logo

    Get the next $CRVL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRVL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CRVL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Feb. 03, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter and year ended December 31, 2025. Revenues for the nine months ended December 31, 2025 were $710 million, a 7% increase from $664 million during the nine months ended December 31, 2024. Earnings per share for the nine months ended December 31, 2025 were $1.53, up 16% compared to $1.32 during the nine months ended December 31, 2024. Revenues for the quarter were $236 million, an increase from $228 million in the December quarter of 2024. Earnings per share for the quarter were $0.47, compared to $0.46 in the same quarter of the prior year.  Third Quarter Fiscal Year 2

    2/3/26 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, February 3, 2026, at 11:30 AM Eastern Time. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols, Chief Financial Officer. The event will also include a dedicated question-and-answer session for attendees. Webcast Details: Date: Tuesday, February 3, 2026Time: 11:30 AM ETAccess: The live

    1/20/26 8:05:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    Sarah Scott Named to Business Insurance's "Women to Watch" List for 2025

    FORT WORTH, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation is proud to announce that Sarah Scott, Executive Vice President of Product and Corporate Services, has been named to Business Insurance's prestigious "Women to Watch" list for 2025. Now celebrating its 20th year, the award honors women who have achieved extraordinary success in insurance and risk management through leadership, innovation, and mentorship. A 26-year veteran of CorVel, Scott has played a pivotal role in advancing the Company's product innovation, clinical integration, and digital transformation initiatives. In her current role, she oversees the development and evolution of CorVel's entire product portfol

    11/18/25 10:44:31 AM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    SEC Filings

    View All

    SEC Form 10-Q filed by CorVel Corp.

    10-Q - CORVEL CORP (0000874866) (Filer)

    2/5/26 4:30:45 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form S-8 filed by CorVel Corp.

    S-8 - CORVEL CORP (0000874866) (Filer)

    11/6/25 4:56:26 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by CorVel Corp.

    10-Q - CORVEL CORP (0000874866) (Filer)

    11/6/25 4:30:50 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Nichols Brian S.

    4 - CORVEL CORP (0000874866) (Issuer)

    2/2/26 9:38:41 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 3 filed by new insider Nichols Brian S.

    3 - CORVEL CORP (0000874866) (Issuer)

    2/2/26 9:37:00 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CEO & President Combs Michael G exercised 28,407 shares at a strike of $51.69 and covered exercise/tax liability with 23,959 shares, increasing direct ownership by 10% to 48,773 units (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    1/7/26 4:28:27 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Leadership Updates

    Live Leadership Updates

    View All

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, February 3, 2026, at 11:30 AM Eastern Time. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols, Chief Financial Officer. The event will also include a dedicated question-and-answer session for attendees. Webcast Details: Date: Tuesday, February 3, 2026Time: 11:30 AM ETAccess: The live

    1/20/26 8:05:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, Oct. 21, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, November 4, 2025, at 11:30 AM Eastern Time. During the webcast, CorVel will also introduce its newly appointed Chief Financial Officer, Brian Nichols. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols. The event will also include a dedicated question-and-answer session for attendees. W

    10/21/25 9:13:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation Appoints Sarah Scott as Executive Vice President of Product

    FORT WORTH, Texas, Feb. 13, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDQ: CRVL), a national provider of risk management solutions, today announced the promotion of Sarah Scott to Executive Vice President of Product. In her expanded role, Sarah will be responsible for defining and driving the overall product vision and strategy, from ideation to launch and ongoing optimization. Sarah's leadership will ensure the company continues to deliver innovative solutions that create value and meet the evolving needs of its partners. Throughout her 25 years with CorVel, Sarah has been instrumental in the company's success. In her previous role as Vice President of Network Solutions, Sarah playe

    2/13/25 7:25:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/14/24 6:45:55 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 5:02:29 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 4:05:36 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Financials

    Live finance-specific insights

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million in the June quarter of 2024. Earnings per share for the quarter were $0.52, compared to $0.42 in the same quarter of the prior year.  The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024. First Quarter Fiscal Year 2026 Highlights  Revenue increased 11% to $235 million, compared to first quarter of fiscal year 2025.Gross profit increased 18% to $5

    8/5/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    STAAR Surgical Announces Changes to Board of Directors

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

    4/24/25 5:00:00 PM ET
    $AZN
    $CRVL
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Specialty Insurers
    Finance